Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

May 10, 2024

Conditions
CABG
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine(Precedex Pfizer) prepared in concentration 0.1 mcg/kg/ml total volume50 ml by nurse anesthetist at preprocedure room, start dexmedetomidine by anesthesiologist at operating room loading 60 ml/hour for 10 minutes before induction of anesthesia then 5ml/hour until the patient on cardiopulmonary bypass (loading 1mcg/kg in 10 minutes then 0.5 mcg/kg/hour). Record patients data by nurse anesthetist

DRUG

Normal saline

Normal Saline total volume50 ml prepared by nurse anesthetist at preprocedure room, start Normal Saline by anesthesiologist at operating room loading 60 ml/hour for 10 minutes before induction of anesthesia then 5ml/hour until the patient on cardiopulmonary bypass. Record patients data by nurse anesthetist

Trial Locations (1)

60000

Sawanpracharak Hospital, Nakhon Sawan

All Listed Sponsors
lead

Sawanpracharak hospital

OTHER

NCT06238011 - Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients | Biotech Hunter | Biotech Hunter